A patient-centered perspective of treating depressive symptoms in chronic heart failure: What do patients prefer?

Patient Education and Counseling
N LossnitzerB Wild

Abstract

To date, very little is known about the specific needs of patients with chronic heart failure (CHF) who must cope with depression. We therefore questioned CHF patients reporting depressive symptoms about their concerns and preferences regarding various psychosocial treatment options. After three-month, we determined how many patients had actually participated in a treatment. 85 patients with CHF fulfilling the criteria of a depressive disorder according to the PHQ-9 were investigated. Data were analyzed using descriptive and frequency, as well as logistic regression analyses. 64.7% of the sample reported that they could envision adhering to supportive talks at longer intervals, whereas only 34.1% would accept an antidepressant. After three months, 24.7% of the patients had actually participated in a treatment. Generalized anxiety severity (GAD-7) was very closely associated with treatment preferences and treatment utilization: The higher the generalized anxiety severity, the more likely was the patients' disposition to begin an antidepressant and/or psychotherapy. The most favoured treatment option was a low-threshold service with supportive talks. Future studies investigating the improvement of patient-centred care in CHF pati...Continue Reading

References

Aug 5, 2000·Clinics in Geriatric Medicine·K E Freedland, R M Carney
Jun 4, 2002·The British Journal of Psychiatry : the Journal of Mental Science·J A HicksS J Wilson
Dec 11, 2002·Circulation·Donald M Lloyd-JonesUNKNOWN Framingham Heart Study
Feb 11, 2005·European Journal of Heart Failure·Jana JüngerMarkus Haass
Mar 11, 2006·European Heart Journal·Jan HeeringaJacqueline C M Witteman
May 24, 2006·Archives of Internal Medicine·Robert L SpitzerBernd Löwe
Oct 10, 2007·Journal of Cardiac Failure·David B BekelmanSydney M Dy
Nov 13, 2008·JAMA : the Journal of the American Medical Association·Brett D ThombsRoy C Ziegelstein
Jun 9, 2009·International Journal of Cardiology·Dimitris TousoulisChristodoulos Stefanadis
Jul 14, 2010·Journal of Psychosomatic Research·Rebecca A GaryAndrew L Smith
Feb 22, 2012·International Journal of Cardiology·Nicole LossnitzerUNKNOWN Competence Network Heart Failure
Sep 4, 2012·Heart & Lung : the Journal of Critical Care·Patricia C WoltzSue Ann Thomas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Heart & Lung : the Journal of Critical Care
Nicole HolzapfelThomas Müller-Tasch
BMJ : British Medical Journal
Douglas E Newton
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
Angélique A SchifferJohan Denollet
© 2022 Meta ULC. All rights reserved